Search | Page 19 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Clofarabine in the treatment of myelodysplastic syndromes

    ... DNA methyltransferase inhibitors, such as azacitidine and decitabine , are standard of care for patients with ...

    Research Review last updated 05/02/2016 - 9:18am.

  2. Prognostic Relevance of the Kinetics of Worsening of Cytopenias in Lower-Risk MDS: A Substudy from the European Leukemianet Low Risk MDS (EUMDS) Registry

    ... treated with a hypomethylating agent (such as Vidaza® [ azacitidine ] or Dacogen® [ decitabine ]), a granulocyte ...

    Research Review last updated 05/02/2016 - 9:27am.

  3. What are the treatments for MDS?

    ... lenalidomide (Revlimid), decitaibine (Dacogen) and azacitidine (Vidaza). Chemotherapy :  Treats MDS by using ...

    FAQ last updated 03/15/2016 - 11:31pm.

  4. Incidence and Burden of the Myelodysplastic Syndromes

    ... receive active therapies even though treatments such as azacitidine and lenalidomide have been shown to decrease red ... to or relapse after therapy with hypomethlating agents (azacitidine and decitabine ) carry a poor prognosis.  These patients ...

    Research Review last updated 05/02/2016 - 9:11am.

  5. PRO#1278: Fludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation (FLUBUTBI)

    ... exception of lenalidomide , decitabine , azacitidine , imatinib mesylate, dasatinib, nilotinib hydrochloride and ...

    Clinical Trial last updated 04/29/2016 - 3:09pm.

  6. Therapies

    ... are three medicines approved in the U.S. to treat MDS. Azacitidine (Vidaza®) and decitabine (Dacogen®) are approved to ...

    Page last updated 03/18/2016 - 11:26am.

  7. Acute Myeloid Leukemia (AML)

    ... chemotherapy drugs. Drugs such as decitabine or azacitidine or hydroxyurea may be better tolerated by older patients. ...

    Topic section last updated 07/07/2016 - 3:15pm.

  8. Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide

    ... , alemtuzumab , or an adequate course of 5- azacitidine or decitabine must have been given within 3 months ...

    Clinical Trial last updated 05/02/2016 - 2:38pm.

  9. Myelodysplastic syndromes: What do hospitalists need to know?

    ... are three standard approaches, including agents such as azacitidine (Vidaza®) and decitabine (Dacogen®), intensive ... and stem cell transplantation.  Patients tend to tolerate azacitidine and decitabine fairly well.  These agents appear to restore normal ...

    Research Review last updated 05/02/2016 - 9:21am.

  10. MDS Drug Information

    ... T risenox azacitidine V idaza ...

    Page last updated 01/20/2015 - 4:46pm.